Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Treatment targets in the management of dyslipidemias: which targets in whom?

Grundy SM.

Curr Cardiol Rep. 2012 Dec;14(6):692-700. doi: 10.1007/s11886-012-0305-7.

PMID:
22956441
2.

Optimal management of combined dyslipidemia: what have we behind statins monotherapy?

Tenenbaum A, Fisman EZ, Motro M, Adler Y.

Adv Cardiol. 2008;45:127-53. doi: 10.1159/0000115192. Review.

PMID:
18230960
3.

[Dyslipidemias and statins: from guidelines to clinical practice. An updated review of the literature].

Lucchi T, Vergani C.

G Ital Cardiol (Rome). 2014 Mar;15(3):149-60. doi: 10.1714/1463.16163. Review. Italian.

PMID:
24770428
5.

Persistent dyslipidemia in Austrian patients treated with statins for primary and secondary prevention of atherosclerotic events - Results of the DYSlipidemia International Study (DYSIS).

Drexel H, Chazelle F, Fauer C, Lautsch D, Gitt AK.

Wien Klin Wochenschr. 2011 Oct;123(19-20):611-7. doi: 10.1007/s00508-011-0057-1. Epub 2011 Sep 29.

PMID:
21947362
6.

A point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive Cardiology.

Joshi PH, Chaudhari S, Blaha MJ, Jones SR, Martin SS, Post WS, Cannon CP, Fonarow GC, Wong ND, Amsterdam E, Hirshfeld JW, Blumenthal RS.

Clin Cardiol. 2012;35(7):404-9. doi: 10.1002/clc.22016. Epub 2012 Jun 6. Review.

7.

Management of dyslipidemias in the presence of the metabolic syndrome or type 2 diabetes.

Matikainen N, Taskinen MR.

Curr Cardiol Rep. 2012 Dec;14(6):721-31. doi: 10.1007/s11886-012-0309-3. Review.

PMID:
22941588
8.

[Update dyslipidemia].

Parhofer KG.

Internist (Berl). 2013 Sep;54(9):1089-103. doi: 10.1007/s00108-013-3335-3. German.

PMID:
23928724
9.

Primary prevention of atherosclerotic cardiovascular disease: controversies and clinical considerations.

Newsom LC.

Ann Pharmacother. 2015 Apr;49(4):484-93. doi: 10.1177/1060028014564181. Epub 2014 Dec 19. Review.

PMID:
25527102
10.

Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).

Ridker PM, MacFadyen JG, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group.

Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):616-23. doi: 10.1161/CIRCOUTCOMES.109.848473. Epub 2009 Sep 22.

11.

Lipid-lowering drug therapy in elderly patients.

Berthold HK, Gouni-Berthold I.

Curr Pharm Des. 2011;17(9):877-93. Review.

PMID:
21418034
12.

Hyperlipidemia: Drugs for Cardiovascular Risk Reduction in Adults.

Last AR, Ference JD, Menzel ER.

Am Fam Physician. 2017 Jan 15;95(2):78-87. Review.

PMID:
28084704
13.

Advantages of lipid-lowering therapy in cerebral ischemia: role of HMG-CoA reductase inhibitors.

Gil-Núñez AC, Villanueva JA.

Cerebrovasc Dis. 2001;11 Suppl 1:85-95. Review.

PMID:
11244205
14.

Treatment of dyslipidemia in children and adolescents.

Holmes KW, Kwiterovich PO Jr.

Curr Cardiol Rep. 2005 Nov;7(6):445-56. Review.

PMID:
16256015
15.

American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis.

Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA; AACE Task Force for Management of Dyslipidemia and Prevention of Atherosclerosis.

Endocr Pract. 2012 Mar-Apr;18 Suppl 1:1-78. No abstract available.

PMID:
22522068
16.

American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary.

Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA; AACE Task Force for Management of Dyslipidemia and Prevention of Atherosclerosis.

Endocr Pract. 2012 Mar-Apr;18(2):269-93. No abstract available.

PMID:
22507559
17.

Treatment of lipid disorders in obesity.

Tonstad S, Després JP.

Expert Rev Cardiovasc Ther. 2011 Aug;9(8):1069-80. doi: 10.1586/erc.11.83. Review.

PMID:
21878051
18.

Emerging therapies for atherosclerosis prevention and management.

Chyu KY, Shah PK.

Cardiol Clin. 2011 Feb;29(1):123-35. doi: 10.1016/j.ccl.2010.10.003. Epub 2010 Dec 17. Review.

PMID:
21257104
19.

[Lipid management--treatment goal and strategy].

Koshiyama H.

Nihon Rinsho. 2006 Nov;64(11):2102-6. Review. Japanese.

PMID:
17087303
20.

Dyslipidemia in the elderly: should it be treated?

Shanmugasundaram M, Rough SJ, Alpert JS.

Clin Cardiol. 2010 Jan;33(1):4-9. doi: 10.1002/clc.20702. Review.

Supplemental Content

Support Center